Results 201 to 210 of about 206,412 (354)
Phosphorylation of cardiac troponin by guanosine 3‘:5‘-monophosphate-dependent protein kinase.
Donald Blumenthal+2 more
openalex +1 more source
Current and novel biomarkers in cardiogenic shock
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko+5 more
wiley +1 more source
AMI with normal ECG and biomarkers of cardiac injury is exceedingly rare. The clinical manifestations of AMI were complex and varied, especially that the patients with atypical AMI were increasing in clinical practice. Caution should be exercised to exclude AMI in patients with chest pain and both normal ECG and biomarkers of cardiac injury.
Ke‐Lan Zha, Wen Chen, Qiang Ye
wiley +1 more source
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors+12 more
wiley +1 more source
Sometimes the easiest way is the best. Simple methods as ST‐segment elevation in III > II and ST‐segment depression in aVL > I are effective diagnostic test for identifying culprit artery in inferior wall ST‐segment elevation myocardial infarction. Complex algorithms are not superior to simple methods.
Peng Zhou+9 more
wiley +1 more source
Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis
Aims Disease‐related changes in body composition are associated with worse outcomes in chronic heart failure. In cardiac amyloidosis (CA), the prognostic value of direct body composition measures is understudied. Methods and results We identified 160 consecutive patients with CA (transthyretin [ATTR] or light chain [AL]) diagnosed between 2001 and 2021
Joshua Longinow+4 more
wiley +1 more source
Abstract This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice.
Giuseppe M.C. Rosano+20 more
wiley +1 more source